Keeler T Homas Management LLC Novo Nordisk A S Transaction History

Keeler T Homas Management LLC

$310 Million
Q3 2024

A detailed history of Keeler T Homas Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Keeler T Homas Management LLC holds 20,072 shares of NVO stock, worth $2.08 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

20,072

Previous 20,101 0.14%

Holding current value

$2.08 Million

Previous $2.87 Million 16.73%

% of portfolio

0.77%

Previous 0.99%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$119.07 - $145.42 $3,453 - $4,217	-29 Reduced 0.14%	20,072 $2.39 Million
Q2 2024 Jul 23, 2024	SELL	$122.71 - $146.91 $815,285 - $976,070	-6,644 Reduced 24.84%	20,101 $2.87 Million
Q1 2024 May 07, 2024	SELL	$102.11 - $135.92 $11,844 - $15,766	-116 Reduced 0.43%	26,745 $3.43 Million
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $187,410 - $225,135	-2,135 Reduced 7.36%	26,861 $2.78 Million
Q3 2023 Oct 26, 2023	BUY	$90.94 - $199.54 $1.26 Million - $2.76 Million	13,827 Added 91.15%	28,996 $2.64 Million
Q2 2023 Jul 21, 2023	SELL	$155.98 - $172.65 $105,130 - $116,366	-674 Reduced 4.25%	15,169 $2.45 Million
Q1 2023 May 02, 2023	SELL	$132.34 - $159.14 $6.25 Million - $7.52 Million	-47,225 Reduced 74.88%	15,843 $2.52 Million
Q4 2022 Jan 19, 2023	SELL	$102.55 - $135.33 $82,552 - $108,940	-805 Reduced 1.26%	63,068 $0
Q3 2022 Oct 24, 2022	BUY	$95.28 - $116.93 $195,895 - $240,408	2,056 Added 3.33%	63,873 $6.36 Million
Q2 2022 Jul 29, 2022	BUY	$103.24 - $121.81 $82,592 - $97,448	800 Added 1.31%	61,817 $6.89 Million
Q1 2022 Apr 28, 2022	BUY	$93.1 - $112.54 $396,885 - $479,758	4,263 Added 7.51%	61,017 $6.78 Million
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $176,515 - $215,544	1,841 Added 3.35%	56,754 $6.36 Million
Q3 2021 Oct 15, 2021	BUY	$84.42 - $106.62 $43,898 - $55,442	520 Added 0.96%	54,913 $5.28 Million
Q2 2021 Jul 27, 2021	BUY	$67.66 - $84.76 $104,331 - $130,699	1,542 Added 2.92%	54,393 $4.56 Million
Q1 2021 Apr 23, 2021	BUY	$67.06 - $75.82 $2.13 Million - $2.4 Million	31,696 Added 149.83%	52,851 $3.57 Million
Q4 2020 Jan 26, 2021	BUY	$63.89 - $73.8 $492,272 - $568,629	7,705 Added 57.29%	21,155 $1.48 Million
Q2 2020 Jul 17, 2020	SELL	$58.54 - $67.94 $2,927 - $3,397	-50 Reduced 0.37%	13,450 $880,000
Q1 2020 Apr 17, 2020	SELL	$49.46 - $64.78 $101,393 - $132,799	-2,050 Reduced 13.18%	13,500 $812,000
Q4 2019 Jan 21, 2020	BUY	$49.86 - $58.26 $22,437 - $26,217	450 Added 2.98%	15,550 $900,000
Q3 2019 Nov 04, 2019	BUY	$47.54 - $53.43 $104,588 - $117,546	2,200 Added 17.05%	15,100 $780,000
Q1 2019 Apr 30, 2019	BUY	$46.36 - $52.63 $101,992 - $115,786	2,200 Added 20.56%	12,900 $674,000
Q4 2018 Jan 24, 2019	BUY	$41.54 - $47.25 $143,562 - $163,296	3,456 Added 47.71%	10,700 $492,000
Q2 2018 Aug 02, 2018	BUY	$44.29 - $50.42 $17,716 - $20,168	400 Added 5.84%	7,244 $334,000
Q4 2017 Feb 07, 2018	BUY	$47.53 - $53.73 $325,295 - $367,728	6,844	6,844 $367,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeler T Homas Management LLC with notifications on news.

Account

Keeler T Homas Management LLC Novo Nordisk A S Transaction History